This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on These Healthcare Stocks: Encompass Health (EHC), Abivax SA Sponsored ADR (ABVX)

Tipranks - Tipranks - Wed Jun 17, 5:00AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Encompass Health (EHC) and Abivax SA Sponsored ADR (ABVX) with bullish sentiments.

Claim 55% Off TipRanks

Encompass Health (EHC)

TD Cowen analyst Ryan Langston maintained a Buy rating on Encompass Health today and set a price target of $125.00. The company’s shares closed last Monday at $99.36.

According to TipRanks.com, Langston is ranked 0 out of 5 stars with an average return of -4.0% and a 41.0% success rate. Langston covers the Healthcare sector, focusing on stocks such as Alignment Healthcare, Privia Health Group, and P3 Health Partners. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Encompass Health with a $136.25 average price target, a 34.1% upside from current levels. In a report issued on June 12, KeyBanc also maintained a Buy rating on the stock.

See today’s best-performing stocks on TipRanks >>

Abivax SA Sponsored ADR (ABVX)

BTIG analyst Julian Harrison maintained a Buy rating on Abivax SA Sponsored ADR yesterday and set a price target of $150.00. The company’s shares closed last Monday at $98.26.

According to TipRanks.com, Harrison is a top 100 analyst with an average return of 44.6% and a 54.1% success rate. Harrison covers the Healthcare sector, focusing on stocks such as MoonLake Immunotherapeutics, Connect Biopharma Holdings, and Mereo Biopharma Group Plc. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Abivax SA Sponsored ADR with a $143.17 average price target, representing a 43.7% upside. In a report issued on June 1, Piper Sandler also maintained a Buy rating on the stock with a $165.00 price target.

Read More on EHC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).